BeiGene Ltd. ADR (BGNE) Social Stream



BeiGene Ltd. ADR (BGNE): $204.21

1.57 (+0.77%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Add BGNE to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#94 of 328

in industry

BEIGENE LTD (BGNE) Price Targets From Analysts

Use the tables below to see what analysts covering BEIGENE LTD think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 5 $431 $343.3 $403.716 $181.47 122.47%
2022-01-06 6 $431 $283.3 $392.46 $181.47 116.27%
2022-01-12 6 $431 $283.3 $388.716 $181.47 114.2%
2022-01-18 6 $431 $283.3 $380.883 $181.47 109.89%
2022-01-28 6 $431 $283.3 $367.55 $181.47 102.54%
2022-02-08 6 $431 $283.3 $354.216 $181.47 95.19%
2022-02-25 6 $431 $283.3 $348.55 $181.47 92.07%
2022-02-28 6 $431 $254 $332.333 $181.47 83.13%
2022-03-17 6 $431 $177 $300.2 $181.47 65.43%
2022-04-28 6 $431 $177 $313.166 $181.47 72.57%
2022-05-06 6 $431 $177 $296.166 $181.47 63.2%
2022-05-18 6 $431 $177 $289.833 $181.47 59.71%
2022-07-27 6 $431 $177 $288.666 $181.47 59.07%
2022-08-05 6 $431 $177 $284.316 $181.47 56.67%
2022-08-09 6 $431 $177 $271.983 $181.47 49.88%
2022-09-17 6 $431 $177 $270.6 $181.47 49.12%
2022-10-03 6 $431 $177 $269.433 $181.47 48.47%
2022-10-13 6 $296 $200 $236.433 $181.47 30.29%
2022-11-14 7 $296 $205 $240.266 $181.47 32.4%
2022-12-12 7 $296 $205 $244.6 $181.47 34.79%
2022-12-15 7 $302 $205 $245.6 $181.47 35.34%
2023-01-19 6 $302 $205 $256.266 $181.47 41.22%
2023-01-24 6 $325 $205 $261.266 $181.47 43.97%
2023-02-07 7 $325 $205 $261.266 $181.47 43.97%
2023-02-20 7 $325 $205 $266.316 $181.47 46.75%
2023-02-28 7 $350 $230.1 $294.183 $181.47 62.11%
2023-04-12 7 $350 $262 $298.883 $181.47 64.7%
2023-04-25 6 $350 $262 $298.883 $181.47 64.7%
2023-05-05 6 $350 $263.3 $305.883 $181.47 68.56%
2023-05-09 6 $350 $263.3 $306.55 $181.47 68.93%
2023-06-26 6 $350 $257 $299.383 $181.47 64.98%
2023-06-30 7 $350 $196 $284.614 $181.47 56.84%
2023-07-12 7 $350 $196 $279.214 $181.47 53.86%
2023-07-17 8 $350 $196 $278.687 $181.47 53.57%
2023-08-03 8 $350 $196 $276.025 $181.47 52.11%
2023-08-04 8 $350 $196 $277.275 $181.47 52.79%
2023-08-07 8 $350 $196 $277.15 $181.47 52.72%
2023-08-17 8 $350 $196 $275.525 $181.47 51.83%
2023-09-06 8 $350 $196 $275.275 $181.47 51.69%
2023-09-12 9 $350 $196 $275.677 $181.47 51.91%
2023-09-20 9 $350 $196 $273.888 $181.47 50.93%
2023-09-28 9 $350 $196 $275.555 $181.47 51.85%
2023-10-16 9 $350 $180.1 $272.011 $181.47 49.89%
2023-10-26 9 $350 $180.1 $262.9 $181.47 44.87%
2023-10-27 9 $350 $180.1 $262.344 $181.47 44.57%
2023-11-10 9 $350 $196 $264.333 $181.47 45.66%
2023-11-15 9 $350 $196 $264.222 $181.47 45.6%

The Trend in the Analyst Price Target


Over the past 42 months, BGNE's average price target has gone up $73.99.

Over the past 43 weeks, BGNE's average upside potential has been 33.34%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-26 7 325 205.0 261.266 261.63 -0.14%
2023-04-12 6 350 230.1 293.350 254.88 15.09%
2023-06-30 7 350 196.0 284.614 178.30 59.63%
2023-08-03 8 350 196.0 276.025 205.82 34.11%
2023-09-21 9 350 196.0 275.555 187.78 46.74%

BGNE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.44 7 0 2 0 0 9

The Trend in the Broker Recommendations


BGNE's average broker recommendation rating improved by 0.13 over the prior 45 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • BGNE has a higher average analyst price target than 5462.68% of all US stocks.
  • BGNE has a higher number of analysts covering the stock than 612.34% of stocks in the large market cap category.
  • BEIGENE LTD's upside potential (average analyst target price relative to current price) is greater than 4778.8% of stocks in the large market cap category.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, BEIGENE LTD's variance in analysts' estimates is lower than -1906.73% of them.

In the Pharmaceutical Products industry, GRFS, CTLT, and PRGO are the three stocks most similar to BEIGENE LTD regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding BGNE using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!